Business
WeWork Edges Closer to Bankruptcy, Stock in Freefall
WeWork, the SoftBank Group-backed flexible workspace provider, is poised to file for bankruptcy as early as next week, according to a reliable source familiar with...
Mullen Automotive Sees Uptick in Stock Amidst Recent Declines
Mullen Automotive, a prominent American automotive and electric vehicle manufacturer, experienced a surge in its stock prices on Tuesday, signaling a potential reversal of recent...
Pfizer Reports First Quarterly Loss Since 2019 Amid Shifting Market Dynamics
In a notable turn of events, pharmaceutical giant Pfizer disclosed its first quarterly loss since 2019 on Tuesday. This downturn was attributed to waning demand...
Caterpillar Delivers Impressive Q3 Profits, Surpassing Analyst Expectations
Caterpillar Inc, the Texas-based heavy equipment manufacturer, announced a substantial surge in third-quarter (Q3) profits on Tuesday, surpassing projections on Wall Street. This uptick in...
Micromobility Stock Performance Reflects Industry’s Turbulent Times
Micromobility, a leading provider of electric micro-mobility services, experienced a drop in its stock performance on Tuesday, following an unforeseen spike in its stock value...
IP Australia Grants Patent to SciSparc for Opioid-Based Treatment Innovation, Stock Soars
Stock value of SciSparc, a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous...
Surprising Surge in Stock of Pop Culture Group Defies Market Expectations
In an unforeseen turn of events, Pop Culture Group, a China-based holding company specializing in the development and hosting of hip-hop events, experienced an unexpected...
Inseego Appoints Steve Harmon as Chief Revenue Officer, Stock Surges
Inseego, a global leader in 5G and IoT solutions, announced yesterday the appointment of Steve Harmon as Chief Revenue Officer, a role newly created within...
Galera Therapeutics’ Stock Dips on FDA’s Phase 3 Trial Directive
Galera Therapeutics, a leading biopharmaceutical company, recently disclosed receiving official meeting minutes from a Type A meeting with the Food and Drug Administration (FDA) held...
GeneDx Q3 Results: 40% YoY Growth, $53M in Revenue, Stock Continues Decline
GeneDx Holdings Corp, a leading provider of enhanced health insights through genomic and clinical expertise, unveiled its revenue results for the third quarter (Q3) of...
